David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Abercrombie & Fitch
ANF
$4.97B
| $35.2M | 0.05% |
1,283,878
+1,070,577
| +502% | +$24M |
|
477
CALL
Mercado Libre
MELI
$99.3B
| $35.1M | 0.05% |
69,200
+800
| +1% | +$319K |
|
478
LPL Financial
LPLA
$28.7B
| $35M | 0.05% |
502,388
-36,032
| -7% | -$2.6M |
|
479
CF Industries
CF
$19.5B
| $35M | 0.05% |
855,117
+735,677
| +616% | +$31.2M |
|
|
X
480
PUT
DELISTED
US Steel
X
| $35M | 0.05% |
1,793,400
-418,300
| -19% | -$8.9M |
|
481
Teck Resources
TECK
$34.3B
| $34.9M | 0.05% |
1,507,502
-1,454,607
| -49% | -$32.8M |
|
482
Timken Company
TKR
$8.53B
| $34.5M | 0.04% |
790,982
+78,200
| +11% | +$3.32M |
|
483
Wyndham Hotels & Resorts
WH
$5.49B
| $34.4M | 0.04% |
688,320
-101,516
| -13% | -$5.13M |
|
484
CALL
United Parcel Service
UPS
$87.3B
| $34.4M | 0.04% |
307,700
-129,800
| -30% | -$13.8M |
|
|
PPLI
485
People Inc
PPLI
$2.88B
| $34.3M | 0.04% |
914,625
-357,636
| -28% | -$13.2M |
|
|
SAVE
486
DELISTED
Spirit Airlines, Inc.
SAVE
| $34.2M | 0.04% |
647,867
+146,532
| +29% | +$8.43M |
|
487
Thermo Fisher Scientific
TMO
$232B
| $34.2M | 0.04% |
124,990
+94,482
| +310% | +$23.5M |
|
488
Moog Inc Class A
MOG.A
$12B
| $34.2M | 0.04% |
393,228
+40,214
| +11% | +$3.5M |
|
489
Nu Skin
NUS
$232M
| $34.1M | 0.04% |
713,303
+268,884
| +61% | +$16.3M |
|
490
Ralph Lauren
RL
$22.1B
| $34.1M | 0.04% |
263,247
+154,230
| +141% | +$18.4M |
|
491
State Street SPDR Dow Jones International Real Estate ETF
RWX
$267M
| $34.1M | 0.04% |
868,904
-85,148
| -9% | -$3.25M |
|
492
Dana Inc
DAN
$3.26B
| $34.1M | 0.04% |
1,921,583
+2,439
| +0.1% | +$43.3K |
|
493
VF Corp
VFC
$5.63B
| $33.8M | 0.04% |
413,369
+397,203
| +2,457% | +$31M |
|
494
Trane Technologies
TT
$99B
| $33.6M | 0.04% |
311,517
-26,270
| -8% | -$2.66M |
|
495
HCA Healthcare
HCA
$92.7B
| $33.6M | 0.04% |
257,899
+15,846
| +7% | +$2.13M |
|
496
Genuine Parts
GPC
$18.6B
| $33.6M | 0.04% |
300,026
+180,082
| +150% | +$18.6M |
|
497
Avista
AVA
$3.17B
| $33.4M | 0.04% |
822,700
+566,659
| +221% | +$23.3M |
|
498
PTC Therapeutics
PTCT
$5.94B
| $33.2M | 0.04% |
882,636
-113,434
| -11% | -$3.81M |
|
499
Tandem Diabetes Care
TNDM
$1.55B
| $33M | 0.04% |
519,524
+483,553
| +1,344% | +$25.4M |
|
|
HMSY
500
DELISTED
HMS Holdings Corp.
HMSY
| $32.9M | 0.04% |
1,111,822
+136,971
| +14% | +$4.23M |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.